Most incrementally modified drugs approved last year were antihypertensives with 7 products
Just like new drugs, incrementally modified drugs that are being developed by Korean pharmaceutical companies are also experiencing a drought as well.
According to the Ministry of Food and Drug Safety, there were 11 products approved as incrementally modified drug last year, which got cut in hal...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
